Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation

Blood

Volumn 92, Issue 3, 1998, Pages 810-821

  Uckun, Fatih M ^a   Herman Hatten, Kim ^b   Crotty, Mya Lisa ^b   Sensel, Martha G ^b   Sather, Harland N ^b   Tuel Ahlgren, Lisa ^b   Sarquis, Mireille B ^b   Bostrom, Bruce ^b   Nachman, James B ^b   Steinherz, Peter G ^b   Gaynon, Paul S ^b   Heerema, Nyla ^b  

^a PARKER HUGHES INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CANCER RISK; CHILD; CHROMOSOME 11Q; CHROMOSOME 4Q; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 4; DIAGNOSTIC VALUE; FETUS; GENE FUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 4; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FETAL PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LIVER; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; PROGNOSIS; REMISSION INDUCTION; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TRANSLOCATION, GENETIC; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS;

EID: 0032147091     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Look AT, Kirsch IR: Molecular basis of childhood cancer, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatrie Oncology. Philadelphia, PA, Lippincott-Raven, 1997, p 37
2. Margolin JF, Poplack DG: Acute lymphoblastic leukemia, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatrie Oncology. Philadelphia, PA, Lippincott-Raven, 1997, p 409
3. Bloomfield CD, Goldman AI, Alimena G, Berger R, Gorgstrorn GH, Brandt L, Catovsky D, de la Chapelle A, Dewald GW, Garson OM: Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 67:415, 1986
4. Ribeiro RC, Abromowitch M, Raimondi SC, Murphy SB, Behm F, Williams DL: Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia. Blood 70: 948, 1987
5. Cimino G, Moir DT, Canaani O, Williams K, Crist WM, Katzav S, Cannizzaro L, Lange B, Nowell PC, Croce CM: Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22; q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res 51:6712, 1991
6. Gu Y, Cimino G, Alder H, Nakamura T, Prasad R, Canaani O, Moir DT, Jones C, Nowell PC, Croce CM: The (4;11)(q21;q23) chromosome translocations in acute leukemias involve the VDJ recombinase. Proc Natl Acad Sci USA 89:10464, 1992
7. Rowley JD, Diaz MO, Espinosa R, Patel YD, vanMelle E, Ziemin S, Taillon-Miller P, Lichter P, Evans GA, Kersey JH: Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: Identification of 11q23 translocation breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci USA 87:9358, 1990
8. Morrissey J, Tkachuk DC, Milatovich A, Francke U, Link M, Cleary ML: A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias. Blood 81:1124, 1993
9. Domer PH, Fakharzadeh SS, Chen CS, Jockel J, Johansen L, Silverman GA, Kersey JH, Korsmeyer SJ: Acute mixed-lineage leukemia t(4;l1)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci USA 90:7884, 1993
10. Ridge SA, Wiedemann LM: Chromosome 11q23 abnormalities in leukaemia. Leuk Lymphoma 14:11, 1994
11. Downing JR, Head DR, Raimondi SC, Carroll AJ, Curcio-Brint AM, Motroni TA, Hulshof MG, Pullen J, Domer PH: The der(11)encoded MLL/AF4 fusion transcript is consistently detected in t(4; 11)(q21;q23)-containing acute lymphoblastic leukemia. Blood 83:330, 1994
12. Heerema NA, Palmer CG, Baehner RL: Karyotypic and clinical findings in a consecutive series of children with acute lymphocytic leukemia. Cancer Genet Cytogenet 17:165, 1985
13. Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner J, Heerema N, Leonard M, Sather HN, Pendergrass T, Johnstone H, O'Brien R, Steinherz P, Zeltzer P, Gaynon P, Trigg M, Uckun FM: Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on consecutive trials of the Children's Cancer Group. J Clin Oncol 1998 (in press)
14. Pui CH, Frankel LS, Carroll AJ, Raimondi SC, Shuster JJ, Head DR, Crist WM, Land VJ, Pullen DJ, Steuber CP: Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 cases. Blood 77:440, 1991
15. Hilden JM, Frestedl JL, Moore RO, Heerema NA, Arthur DC, Reaman GH, Kersey JH: Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptasepolymerase chain reaction for t(4; 11)(q21; q23). Blood 86:3876, 1995
16. Behm FG, Raimondi SC, Frestedt JL, Liu Q, Crist WM. Downing JR, Rivera GK. Kersey JH, Pui CH: Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 87:2870, 1996
17. Ford AM, Ridge SA, Cabrera ME, Mahmoud H. Steel CM, Chan LC, Greaves M: In utero rearrangements in the tri thorax-related oncogene in infant leukaemias. Nature 363:358, 1993
18. Tkachuk DC, Kohler S, Cleary ML: Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71:691, 1992
19. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM, Canaani E: The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71:70l, 1992
20. Zeleznik-Le NJ, Harden AM, Rowley JD: 11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene. Proc Natl Acad Sci USA 91:10610, 1994
21. Downing JR, Look AT: MLL fusion genes in the 11q23 acute leukemias, in Freireich EJ, Kantarjian H (eds): Leukemia: Advances in Research and Treatment. Boston, MA, Academic, 1995
22. Nakamura T, Alder H, Gu Y, Prasad R, Canaani O, Kamada N, Gale RP, Lange B, Crist WM, Nowell PC: Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci USA 90:4631, 1993
23. Chen CS, Hilden JM, Frestedt J, Domer PH, Moore R, Korsmeyer SJ, Kersey JH: The chromosome 4q21 gene (AF-4/FEL) is widely expressed in normal tissues and shows breakpoint diversity in t(4;11)(q21;q23) acute leukemia. Blood 82:1080, 1993
24. Rowley JD: The der(11) chromosome contains the critical breakpoint junction in the 4:11, 9:11. and 11:19 translocations in acute leukemia. Genes Chromosom Cancer 5:264, 1992
25. Cimino G, Nakamura T, Gu Y, Canaani O, Prasad R, Crist WM, Carroll AJ, Baer M, Bloomfield CD, Nowell PC: An altered 11-kilobase transcript in leukemic cell lines with the t(4;11)(q21;q23) chromosome translocation. Cancer Res 52:3811, 1992
26. Chen CS, Medberry PS. Arthur DC. Kersey JH: Breakpoint clustering in t(4;11)(q21;q23) acute leukemia. Blood 78:2498, 1991
27. Rubnitz JE, Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, Pullen DJ, Cleary ML: Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: A Pediatrie Oncology Group study. Blood 84:570, 1994
28. Chen CS, Sorensen PH, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, Hammond GD, Kersey JH: Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 81:2386. 1993
29. Griesinger F, Elfers H, Ludwig WD, Falk M. Rieder H, Harbott J, Lampert F, Heinze B, Hoelzer D, Thiel E: Detection of HRX-FEL fusion transcripts in pre-pre-B-ALL with and without cytogenetic demonstration of t(4;11). Leukemia 8:542, 1994
30. Limpens J, de Jong D. van Krieken JH, Price CG, Young BD, van Ommen GJ, Kluin PM: BCL-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6:2271, 1991
31. Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ, Schuuring E, Kluin PM: Lymphoma-associated translocation t(14; 18) in blood B cells of normal individuals. Blood 85:2528, 1995
32. Aster JC, Kobayashi Y, Shiota M, Mori S, Sklar J: Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am J Pathol 141:291, 1992
33. Liu Y, Hernandez AM, Shibata D, Cortopassi GA: BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA 91:8910, 1994
34. Ji W, Qu GZ, Ye P, Zhang XY, Halabi S, Ehrlich M: Frequent detection of bcl-2/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay. Cancer Res 55:2876, 1995
35. Dolken G, Illerhaus G, Hirt C. Mertelsmann R: BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol 14:1333, 1996
36. Levine EG, Arthur DC, Frizzera G, Peterson BA, Hurd DD, Bloomfield CD: There are differences in cytogenetic abnormalities among histologie subtypes of the non-Hodgkin's lymphomas. Blood 66:1414, 1985
37. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M: Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med 316:79, 1987
38. Biennaux C, Loos M, Sels A, Huez G, Stryckmans P: Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86:3118, 1995
39. Uckun FM, Sather H, Gaynon P, Arthur D, Trigg M, Tubergen D, Nachman J, Steinherz P, Sensel M, Reaman G: Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood 90:28, 1997
40. Heerema NA, Arthur DC, Sather H, Albo V, Feusner J, Lange BJ, Steinherz PG, Zeltzer P, Hammond D, Reaman GH: Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: Impact of the 11q23 breakpoint on outcome: A report of the Children's Cancer Group. Blood 83:2274, 1994
41. Mitelman F: ISCN: An International System for Human Cytogenetic Nomenclature. Basel, Switzwerland, Karger, 1995
42. Uckun FM, Downing JR, Gunther R, Chelstrom LM, Finnegan D, Land VJ, Borowitz MJ, Carroll AJ, Crist WM: Human t(1;19)(q23; p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 81:3052, 1993
43. Uckun FM, Downing JR, Chelstrom LM, Gunther R, Ryan M, Simon J, Carroll AJ, Tuel-Ahlgren L, Crist WM: Human t(4;11)(q2l; q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 84:859, 1994
44. Gaynon PS, Crotty ML, Sather HN, Bostrom BC, Nachman JB, Steinherz PG, Heerema NA, Sarquis M, Tuel-Ahlgren L, Uckun FM: Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: A Children's Cancer Group Initiative. Leuk Lymphoma 26:57, 1997
45. Koller E, Karlic H, Krieger O, Mistrik M, Michlmayr G, Gadner H, Lutz D, Heinz R, Pittermann E: Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia. Ann Hematol 70:75, 1995
46. Repp R, Borkhardt A, Haupt E. Kreuder J, Brettreich S, Hammermann J, Nishida K, Harbott J, Lampert F: Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis. Leukemia 9:210, 1995
47. Kwok S, Higuchi R: Avoiding false positives with PCR. Nature 339:237, 1993
48. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
49. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966
50. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II. Analysis and examples. Br J Cancer 35:1, 1977
51. Uckun FM, Gaynon P, Sensel M, Nachman J, Trigg M, Steinherz P, Hutchinson R, Bostrom B, Lange B, Sather H, Reaman G: Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: A Children's Cancer Group Study. J Clin Oncol 15:2214, 1997
52. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reaman G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia [see comments]. J Clin Oncol 14:18, 1996
53. Uckun FM, Waurzyniak BJ, Sensel MG, Chelstrom L, Crotty ML, Gaynon PS, Reaman GH: Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice. Leuk Lymphoma 1998 (in press)
54. Yu BD, Hess JL, Horning SE, Brown GA, Korsmeyer SJ: Altered Hox expression and segmental identity in Mil-mutant mice. Nature 378:505, 1995
55. Yarkoni S, Lishner M, Tangi I. Nagler A, Lorberboum-Galski H: B-cell non-Hodgkin's lymphoma: Evidence for the t (14;18) translocation in all hematopoietic cell lineages. J Natl Cancer Inst 88:973, 1996
56. Williams DL, Harber J, Murphy SB, Look AT, Kalwinsky DK, Rivera G, Melvin SL, Stass S, Dahl GV: Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. Blood 68:205, 1986
57. Dewald GW, Schad CR, Christensen ER, Tiede AL, Zinsmeister AR, Spurbeck JL, Thibodeau SN, Jalal SM: The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CMLand ALL. Cancer Genet Cytogenet 71:7, 1993
58. Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD: Cloning of ELL, a gene that fuses to MLL in a t( 11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 91:12110, 1994
59. Rubnitz JE, Morrissey J. Savage PA, Cleary ML: ENL, the gene fused with HRX in t(11:19) leukemias. encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood 84:1747, 1994
60. Janssen JW, Ludwig WD, Borkhardt A, Spadinger U, Rieder H, Fonatsch C, Hossfeld DK, Harbott J, Schulz AS, Repp R: Pre-pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission. Blood 84:3835, 1994